BusinessWeek takes a high-level look at funding and progress in stem cell research in Asia: “The progress the Asians have made is ‘astonishing,’ says Robert A. Goldstein, chief scientific officer at New York-based Juvenile Diabetes Research Foundation International, which has teamed up with Singapore in funding ES Cell’s efforts to find a cure for the disease.” The authors views this as a competition – as do most of the participants and principles, no doubt – but a rising tide in medical science raises all boats. Successes in any country (and even business or competitive failures) in stem cell research still advance knowledge, capabilities and the potential for healthy longevity worldwide.
View the Article Under Discussion: http://www.businessweek.com/magazine/content/05_02/b3915052.htm
Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/
http://www.longevitymeme.org/news/view_news_item.cfm?news_id=1409
